Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume 138, Issue 3, Pages 280-292
Publisher
Wiley
Online
2012-11-30
DOI
10.1111/imm.12037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IFN- Induces Transcription of Hypoxia-Inducible Factor-1 to Inhibit Proliferation of Human Endothelial Cells
- (2014) S. A. Gerber et al. JOURNAL OF IMMUNOLOGY
- Radiation-Induced IFN- Production within the Tumor Microenvironment Influences Antitumor Immunity
- (2014) A. A. Lugade et al. JOURNAL OF IMMUNOLOGY
- Vaccines Targeting Tumor Blood Vessel Antigens Promote CD8+ T Cell-Dependent Tumor Eradication or Dormancy in HLA-A2 Transgenic Mice
- (2012) X. Zhao et al. JOURNAL OF IMMUNOLOGY
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses
- (2012) Thomas Höfer et al. Frontiers in Immunology
- IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
- (2011) John B. Mumm et al. CANCER CELL
- Targeting Regulatory T Cells in Cancer
- (2011) W. L. Byrne et al. CANCER RESEARCH
- Enhancement of T-cell-Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer
- (2011) R. P. M. Dings et al. CLINICAL CANCER RESEARCH
- Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cells
- (2011) Alessia Burocchi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD8+ T Cells: Foot Soldiers of the Immune System
- (2011) Nu Zhang et al. IMMUNITY
- Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
- (2011) Sergio A. Quezada et al. IMMUNOLOGICAL REVIEWS
- Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases
- (2011) John Puskas et al. IMMUNOLOGY
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
- (2011) Daniel T. Fisher et al. JOURNAL OF CLINICAL INVESTIGATION
- Chronic Chemoimmunotherapy Achieves Cure of Spontaneous Murine Mammary Tumors via Persistent Blockade of Posttherapy Counter-Regulation
- (2011) Rachael B. Rowswell-Turner et al. JOURNAL OF IMMUNOLOGY
- Highly Activated Cytotoxic CD8 T Cells Express Protective IL-10 at the Peak of Coronavirus-Induced Encephalitis
- (2011) K. Trandem et al. JOURNAL OF IMMUNOLOGY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Development of Novel Combination Therapies
- (2011) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer
- (2010) Tom Donnem et al. CANCER
- IL-2 Complex Treatment Can Protect Naive Mice from Bacterial and Viral Infection
- (2010) S. E. Hamilton et al. JOURNAL OF IMMUNOLOGY
- IL-12 Suppresses Vascular Endothelial Growth Factor Receptor 3 Expression on Tumor Vessels by Two Distinct IFN-γ–Dependent Mechanisms
- (2010) Elizabeth W. Sorensen et al. JOURNAL OF IMMUNOLOGY
- T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses
- (2010) Y. Zhu et al. JOURNAL OF IMMUNOLOGY
- Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells
- (2010) C. Krieg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functions of γC cytokines in immune homeostasis: Current and potential clinical applications
- (2009) Willem W. Overwijk et al. CLINICAL IMMUNOLOGY
- Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo
- (2009) B. Hirsch et al. CURRENT DRUG TARGETS
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
- (2009) Ethan M. Shevach IMMUNITY
- Regulatory T cells overturned: the effectors fight back
- (2009) Lucy S. K. Walker IMMUNOLOGY
- Dormancy of metastatic melanoma
- (2009) Liliana Ossowski et al. Pigment Cell & Melanoma Research
- Local therapy of cancer with free IL-2
- (2008) Willem Den Otter et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Homeostatic Proliferation Plus Regulatory T-Cell Depletion Promotes Potent Rejection of B16 Melanoma
- (2008) J. Kline et al. CLINICAL CANCER RESEARCH
- Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
- (2008) J. Marlind et al. CLINICAL CANCER RESEARCH
- Regulatory T cells and treatment of cancer
- (2008) Tyler J Curiel CURRENT OPINION IN IMMUNOLOGY
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
- (2008) Qizhi Tang et al. IMMUNITY
- Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
- (2008) Todd M. Brusko et al. IMMUNOLOGICAL REVIEWS
- Cancer Immunotherapy — The Endgame Begins
- (2008) Louis M. Weiner NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started